A Comparative Analysis of Acute Kidney Injury Severity and Associated Factors in Diabetic and Non-Diabetic Patients Following Myocardial Infarction
Main Article Content
Abstract
Background: Acute kidney injury is an important complication of myocardial infarction, but comparative evidence describing renal, glycaemic, and cardiac differences between diabetic and non-diabetic patients with established post-MI AKI remains limited. Objective: To compare AKI severity and associated renal, glycaemic, and cardiac parameters between diabetic and non-diabetic patients following myocardial infarction. Methods: This comparative cross-sectional study included 248 post-MI patients with AKI recruited from the Punjab Institute of Cardiology and Mayo Hospital, Lahore, comprising 124 diabetic and 124 non-diabetic participants. AKI was classified using KDIGO serum creatinine criteria. Categorical variables were compared using Chi-square tests, and non-normally distributed continuous variables were analysed using the Mann–Whitney U test. Results: Overall, 50.0% had Stage 2 and 30.6% had Stage 3 AKI. Diabetes status was strongly associated with random blood glucose category (χ²(2) = 91.681, p < 0.001; Cramér’s V = 0.608), HbA1c category (χ²(2) = 153.249, p < 0.001; Cramér’s V = 0.786), and absolute serum creatinine category (χ²(2) = 25.451, p < 0.001; Cramér’s V = 0.320). Significant continuous-variable differences were observed for eGFR (p = 0.015), initial troponin (p = 0.033), and random blood glucose (p < 0.001), whereas serum creatinine, urea, blood urea nitrogen, and LVEF were not significantly different. Conclusion: Diabetic and non-diabetic post-MI patients with AKI demonstrated distinct renal, glycaemic, and cardiac profiles. Comprehensive assessment is warranted irrespective of documented diabetes status
Article Details
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
1. Zhao H, Miao R, Lin F, Zhao G. Risk score for prediction of acute kidney injury in patients with acute ST-segment elevation myocardial infarction. Dis Markers. 2022;2022.
2. Ikizler TA, Parikh CR, Himmelfarb J, Chinchilli VM, Liu KD, Coca SG, et al. A prospective cohort study of acute kidney injury and kidney outcomes, cardiovascular events, and death. Kidney Int. 2021;99(2):456-65.
3. Wu Y, Pan N, An Y, Xu M, Tan L, Zhang L. Diagnostic and prognostic biomarkers for myocardial infarction. Front Cardiovasc Med. 2021;7:617277.
4. Oh MS, Choi SW, Jeong MH, Bae EH, Park J, Ryu SY, et al. Association between decreased estimated glomerular filtration rates and long-term mortality in Korean patients with acute myocardial infarction. Chonnam Med J. 2023;59(1):87-97.
5. Kanabar K, Sharma YP, Krishnappa D, Santosh K, Dhudasia M. A study of the predictive role of multiple variables for the incidence of acute kidney injury and its outcomes in Indian patients with ST-elevation myocardial infarction and cardiogenic shock. Egypt Heart J. 2024;76(1).
6. Dutta A, Saha S, Bahl A, Mittal A, Basak T. A comprehensive review of acute cardio-renal syndrome: need for novel biomarkers. Front Pharmacol. 2023;14:1152055.
7. Kampmann JD, Heaf JG, Mogensen CB, Petersen SR, Wolff DL, Mickley H, et al. Rate and risk factors of acute myocardial infarction after debut of chronic kidney disease: results from the KidDiCo. J Cardiovasc Dev Dis. 2022;9(11):387.
8. Carreira A, Castro P, Mira F, Melo M, Ribeiro P, Santos L. Acute kidney injury: a strong risk factor for hypoglycaemia in hospitalized patients with type 2 diabetes. Acta Diabetol. 2023;60(9):1179-85.
9. Miura T, Kuno A, Tanaka M. Diabetes modulation of the myocardial infarction–acute kidney injury axis. Am J Physiol Heart Circ Physiol. 2022;322(3):H394-405.
10. Glynn L, Hofmann R, Lind M, Andersson T, Nyström T, Eliasson B. Trends in survival after first myocardial infarction in people with diabetes. J Am Heart Assoc. 2024;13(10):e034741.
11. Ding Q, Funk M, Spatz ES, Lin H, Batten J, Wu E, et al. Sex-specific impact of diabetes on all-cause mortality among adults with acute myocardial infarction: an updated systematic review and meta-analysis, 1988–2021. Front Endocrinol (Lausanne). 2022;13:918095.
12. Thanapongsatorn P, Tanomchartchai A, Assavahanrit J. Long-term outcomes of acute kidney injury in acute decompensated heart failure: identifying true cardiorenal syndrome and unveiling prognostic significance. Kidney Res Clin Pract. 2024;43(4):480-91.
13. Gao S, Liu Q, Chen H, Yu M, Li H. Predictive value of stress hyperglycemia ratio for the occurrence of acute kidney injury in acute myocardial infarction patients with diabetes. BMC Cardiovasc Disord. 2021;21(1).
14. Mezgebu Y, Alemu S, Mohamed MA, Shibru H, Hailu W. Acute kidney injury and its associated factors among patients with acute decompensated heart failure admitted to the University of Gondar Hospital, Northwest Ethiopia: a hospital-based cross-sectional study. BMC Nephrol. 2024;25(1).
15. Li X, Qiao Y, Ruan L, Xu S, Fan Z, Liu S, et al. Stress hyperglycemia ratio as an independent predictor of acute kidney injury in critically ill patients with acute myocardial infarction: a retrospective US cohort study. Ren Fail. 2025;47(1):2471018.
16. Saha T, Soliman-Aboumarie H. Review of current management of myocardial infarction. J Clin Med. 2025;14(9):3082.
17. Schmitz T, Wein B, Raake P, Heier M, Peters A, Linseisen J, et al. Do patients with diabetes with new-onset acute myocardial infarction present with different symptoms than non-diabetic patients? Front Cardiovasc Med. 2024;11:1324451.
18. Pakfetrat M, Nikoo MH, Malekmakan L, Tabande M, Roozbeh J, Ganbar Ali RJ, et al. Comparison of risk factors for contrast-induced acute kidney injury between patients with and without diabetes. Hemodial Int. 2010;14(4):387-92.
19. Nong Y, Wei X, Qiu H, Yang H, Yang J, Lu J, et al. Analysis of risk factors for severe acute kidney injury in patients with acute myocardial infarction: a retrospective study. Front Nephrol. 2023;3.
20. Ülger P, Yildiz E, Tyczynski B, Findeisen H, Kribben A, Janssen OE, et al. Effect of stress hyperglycaemia on acute kidney injury in non-diabetic critically ill patients? Int Urol Nephrol. 2023;55(12):3253-9.
21. Amod A, Buse JB, McGuire DK, Pieber TR, Pop-Busui R, Pratley RE, et al. Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: an exploratory analysis (DEVOTE 12). Diab Vasc Dis Res. 2020;17(6).
22. Kaur A, Sharma GS, Kumbala DR. Acute kidney injury in diabetic patients: a narrative review. Medicine (Baltimore). 2023;102(20):e33888.
23. Bueno Junior CR, Bano A, Tang Y, Sun X, Abate A, Hall E, et al. Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort. Cardiovasc Diabetol. 2023;22(1).
24. Wanner C, Schuchhardt J, Bauer C, Brinker M, Kleinjung F, Vaitsiakhovich T. Associations between intercurrent events and cardiorenal clinical outcomes in non-diabetic chronic kidney disease: a real-world retrospective cohort study in the United States. BMC Nephrol. 2025;26(1).
25. Bonet G, Carrasquer A, Peiró ÓM, Sanchez-Gimenez R, Lal-Trehan N, del-Moral-Ronda V, et al. Clinical characteristics and prognostic implications of diabetes and myocardial injury in patients admitted to the emergency room. BMC Cardiovasc Disord. 2021;21(1).
26. Mo M, Huang Z, Gao T, Luo Y, Pan X, Yang Z, et al. Development and validation of a short-term renal prognosis prediction model in diabetic patients with acute kidney injury. Diabetol Metab Syndr. 2022;14:190.